fbpx

News

Press Release - August 25th, 2020

SubjectWell Recruits Patients for COVID-19 Vaccine Clinical Trials, Works to Address Lack of Racial Diversity in Patient Recruitment To Date

Austin, TX, August 25, 2020 – SubjectWell, the largest risk-free clinical trials marketplace, announced today it is working with leading pharmaceutical companies to recruit patients for Phase 2 and Phase 3 COVID-19 vaccine trials. The company is leveraging its expansive marketplace of millions of patients nationwide and its dedicated registry of patients willing to participate in

Press Release - May 13th, 2020

SubjectWell Offers Researchers Registry of 10K+ Patients Willing to Participate in COVID-19 Research

Austin, TX, May 13, 2020 – As the pharmaceutical industry mobilizes at unprecedented speed to develop a COVID-19 vaccine, SubjectWell, the world’s largest marketplace for clinical trials, announced today it has developed a growing patient registry of individuals in the US interested in participating in clinical trials for a COVID-19 vaccine as these trials become

News - December 9th, 2019

SubjectWell Partners with Human API to Provide Free Patient Medical Record Retrieval for Clinical Trial Sites and Sponsors

The risk-free clinical trials marketplace will use Human API’s platform to simplify patient-approved health data collection and speed up the randomization process AUSTIN, TX, December 9, 2019 – SubjectWell, the risk-free clinical trial marketplace, has partnered with data-sharing platform Human API to provide free medical record retrieval to clinical trial sites and sponsors. Through this partnership, SubjectWell seeks to